DOCSLIB.ORG

South Dakota Board of Pharmacy Wholesale Distributors; Active, in Good Standing As of October 5, 2018 This Document May Be Used As a Primary Source Verification

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
South Dakota Board of Pharmacy Wholesale Distributors; Active, in Good Standing As of October 5, 2018 This Document May Be Used As a Primary Source Verification South Dakota Board of Pharmacy Wholesale Distributors; Active, in good standing as of October 5, 2018 This document may be used as a Primary Source Verification Full License Firm Name DBA Address 1 Address 2 City State ZIP Code Expiration Issued 600-2353 3M COMPANY dba 3M ESPE DENTAL PRODUCTS 2111 MCGAW AVE IRVINE CA 92614 12/31/2018 11/10/2014 3M COMPANY-CRITICAL & CHRONIC 600-1277 CARE SOLUTIONS DIVISION dba 3M 601 22ND AVE S BROOKINGS SD 57006 12/31/2018 03/19/2007 600-0107 A & B WELDING SUPPLY CO INC 914 E CHICAGO ST RAPID CITY SD 57701 12/31/2018 01/28/1992 600-1251 A.F. HAUSER INC 4401 E US HWY 30 VALPARAISO IN 46383 12/31/2018 01/03/2007 600-2272 A.P.I. SOLUTIONS INC 25309 FRIENDSHIP RD DAPHNE AL 36526 12/31/2018 03/06/2014 ABBVIE PATIENT ASSISTANCE 600-1372 FOUNDATION 1 N WAUKEGAN RD D-ZZ22, BLDG AP34 NORTH CHICAGO IL 60064 12/31/2018 11/20/2007 600-2058 ABBVIE US LLC 1 N WAUKEGAN RD D-GS02 BLDG AP5 NORTH CHICAGO IL 60064 12/31/2018 07/19/2012 600-2299 ABRAXIS BIOSCIENCE LLC 86 MORRIS AVE SUMMIT NJ 07901 12/31/2018 05/22/2014 600-2952 ACACIA PHARMA INC 440 STEVENS AVE, SUITE 200 SOLANA BEACH CA 92075 12/31/2019 09/27/2018 600-2358 ACADIA PHARMACEUTICALS INC 3611 VALLEY CENTRE DR STE 300 SAN DIEGO CA 92130 12/31/2018 11/19/2014 600-2409 ACARIAHEALTH SOLUTIONS INC 6610 W SAM HOUSTON PKWY N#330 HOUSTON TX 77041 12/31/2018 04/06/2015 600-1552 ACCERA INC 3005 CENTER GREEN DR #205 BOULDER CO 80301 12/31/2018 01/08/2009 600-2657 ACCORD BIOPHARMA INC 1009 SLATER RD STE 210-B DURHAM NC 27703 12/31/2018 11/07/2016 600-1472 ACCORD HEALTHCARE INC 1009 SLATER RD STE 210-B DURHAM NC 27703 12/31/2018 06/23/2008 600-1547 ACE SURGICAL SUPPLY CO INC 1034 PEARL STREET BROCKTON MA 02301 12/31/2018 12/22/2008 600-2203 ACELLA PHARMACEUTICALS LLC 1880 MCFARLAND PKWY STE 110 ALPHARETTA GA 30005 12/31/2018 08/27/2013 600-2242 ACELRX PHARMACEUTICALS INC 351 GALVESTON DR REDWOOD CITY CA 94063 12/31/2018 12/11/2013 600-2863 ACETRIS HEALTH LLC 250 PEHLE AVE STE 601 SADDLE BROOK NJ 07663 12/31/2018 01/26/2018 600-2805 ACHAOGEN INC 1 TOWER PL STE 300 SOUTH SAN FRANCISCO CA 94080 12/31/2018 07/27/2017 600-2739 ACI HEALTHCARE USA INC 10100 W SAMPLE RD STE 406 CORAL SPRINGS FL 33065 12/31/2018 02/28/2017 600-2798 ACLARIS THERAPEUTICS INC 640 LEE RD STE 200 WAYNE PA 19087 12/31/2018 07/19/2017 600-1966 ACME DELIVERY SERVICE INC 18101 E COLFAX AVE AURORA CO 80011 12/31/2018 11/23/2011 600-1748 ACORDA THERAPEUTICS INC 420 SAW MILL RIVER RD ARDSLEY NY 10502 12/31/2018 07/02/2010 South Dakota Board of Pharmacy Wholesale Distributors; Active, in good standing as of October 5, 2018 This document may be used as a Primary Source Verification Full License Firm Name DBA Address 1 Address 2 City State ZIP Code Expiration Issued 600-1193 ACTAVIS ELIZABETH LLC 200 ELMORA AVE ELIZABETH NJ 07207 12/31/2018 08/30/2006 600-0910 ACTAVIS LABORATORIES UT INC 575-577-579 CHIPETA WAY SALT LAKE CITY UT 84108 12/31/2018 12/22/2003 600-2061 ACTELION PHARMACEUTICALS US INC 5000 SHORELINE CT STE 200 SOUTH SAN FRANCISCO CA 94080 12/31/2018 07/23/2012 600-2803 ADAMAS PHARMA LLC 1900 POWELL ST STE 750 EMERYVILLE CA 94608 12/31/2018 07/27/2017 ADAMIS PHARMACEUTICALS 600-2494 CORPORATION 11682 EL CAMINO REAL STE 300 SAN DIEGO CA 92130 12/31/2018 11/04/2015 FOUR RADNOR CORPORATE CENTER, 600-2463 ADAPT PHARMA INC 2ND FLOOR 100 MATSONFORD RD 2ND FLR RADNOR PA 19087 12/31/2018 08/19/2015 600-1479 ADARE PHARMACEUTICALS INC 845 CENTER DR VANDALIA OH 45377 12/31/2018 07/15/2008 ADVANCED ACCELERATOR 600-2639 APPLICATIONS USA INC 57 E WILLOW ST MILLBURN NJ 07041 12/31/2018 08/11/2016 600-2704 ADVANCED PHARMA, INC dba AVELLA OF HOUSTON 9265 KIRBY DR HOUSTON TX 77054 12/31/2018 11/03/2015 600-2902 ADVANCED PHARMACEUTICALS LLC 998 N HALSTEAD RD STE C OCEAN SPRINGS MS 39564 12/31/2018 05/23/2018 600-2111 AEGERION PHARMACEUTICALS INC ONE MAIN ST STE 800 CAMBRIDGE MA 02142 12/31/2018 12/20/2012 600-2853 AERIE PHARMACEUTICALS INC 135 US HIGHWAY 206 STE 15 BEDMINSTER NJ 07921 12/31/2018 01/18/2018 600-2573 AERO-MED LTD 5110 W 74TH ST INDIANAPOLIS IN 46268 12/31/2018 03/24/2016 600-2794 AGIOS PHARMACEUTICALS INC 88 SIDNEY ST CAMBRIDGE MA 02139 12/31/2018 07/19/2017 600-2727 AGRI-TECH 1207 9TH AVE SW WATERTOWN SD 57201 12/31/2018 01/26/2017 600-1661 AIDAREX PHARMACEUTICALS LLC 595 N SMITH ST CORONA CA 92880 12/31/2018 11/03/2009 600-2802 AIPING PHARMACEUTICAL INC 350 W WIRELESS BLVD HAUPPAUGE NY 11788 12/31/2018 07/27/2017 600-1401 AIR PRODUCTS AND CHEMICALS INC 4078 HUNT ST PRYOR OK 74362 12/31/2018 01/17/2008 600-1381 AIR PRODUCTS AND CHEMICALS INC 2200 MONROE ST PO BOX 695 GRANITE CITY IL 62040 12/31/2018 11/26/2007 61301- 600-1369 AIR PRODUCTS AND CHEMICALS INC ONE CIVIC ROAD PO BOX 1249 LA SALLE IL 3249 12/31/2018 11/20/2007 600-2432 AIRGAS INC dba AIRGAS USA LLC 5548 MAGNUSON BLVD GILLETTE WY 82718 12/31/2018 06/26/2015 600-2426 AIRGAS INC dba AIRGAS USA LLC 310 CLEVELAND PL CHEYENNE WY 82001 12/31/2018 06/10/2015 600-2411 AIRGAS INC dba AIRGAS USA LLC 3519 SEGER DR UNIT F RAPID CITY SD 57701 12/31/2018 04/16/2015 South Dakota Board of Pharmacy Wholesale Distributors; Active, in good standing as of October 5, 2018 This document may be used as a Primary Source Verification Full License Firm Name DBA Address 1 Address 2 City State ZIP Code Expiration Issued 600-2425 AIRGAS USA LLC 3100 9TH AVE SW STE 300 WATERTOWN SD 57201 12/31/2018 06/10/2015 600-2177 AIRGAS USA LLC 410 SE CREEKVIEW DR ANKENY IA 50021 12/31/2018 06/11/2013 600-1836 AIRGAS USA LLC 410 S CREEK VIEW DR ANKENY IA 50021 12/31/2018 02/04/2011 600-1822 AIRGAS USA LLC 4802 PFLAUM RD MADISON WI 53718 12/31/2018 12/23/2010 600-1694 AIRGAS USA LLC 1601 NICHOLAS BLVD ELK GROVE VILLAGE IL 60007 12/31/2018 02/04/2010 600-0864 AIRGAS USA LLC 2700 BLVD OF CHAMPIONS SIOUX CITY IA 51111 12/31/2018 06/30/2003 600-0627 AIRGAS USA LLC 1420 E BENSON RD SIOUX FALLS SD 57104 12/31/2018 12/08/2000 600-2193 AJANTA PHARMA USA INC ONE GRANDE COMMONS 440 US HWY 22 E, STE 150 BRIDGEWATER NJ 08807 12/31/2018 07/29/2013 600-0472 AKORN INC 5605 CENTERPOINT CT STE B GURNEE IL 60031 12/31/2018 09/28/1998 600-0358 AKORN INC 150 S WYCKLES RD DECATUR IL 62522 12/31/2018 07/25/1996 600-1432 AKRIMAX PHARMACEUTICALS LLC 11 COMMERCE DR 1ST FLR CRANFORD NJ 07016 12/31/2018 03/17/2008 600-2862 AKRON GENERICS LLC 175 COMMERCE DR STE M HAUPPAUGE NY 11788 12/31/2018 01/26/2018 600-2872 AKRON PHARMA INC 373 RT US 46 W, BLDG E STE 117 FAIRFIELD NJ 07004 12/31/2018 02/23/2018 600-2938 ALCON LABORATORIES INC 6601 OAK GROVE RD STE 200 FT WORTH TX 76134 12/31/2018 08/09/2018 600-2219 ALCON LABORATORIES INC 6440 OAK GROVE RD STE 200-B FT WORTH TX 76134 12/31/2018 11/05/2013 600-1922 ALCON LABORATORIES INC 6740 BUSINESS PKWY ELKRIDGE MD 21075 12/31/2018 08/17/2011 600-0126 ALCON LABORATORIES INC 6500 WILL ROGERS BLVD FT WORTH TX 76134 12/31/2018 02/18/1992 600-2500 ALEMBIC PHARMACEUTICALS INC 750 ROUTE 202, SUITE 410 BRIDGEWATER NJ 08807 12/31/2018 11/05/2015 600-1269 ALEXION PHARMACEUTICALS INC 100 COLLEGE ST NEW HAVEN CT 06093 12/31/2018 02/22/2007 600-2439 ALEXSO INC 2317 COTNER AVE LOS ANGELES CA 90064 12/31/2018 06/30/2015 600-2165 ALFASIGMA USA INC 2008 CLAIBORNE AVE SHREVEPORT LA 71103 12/31/2018 05/10/2013 600-1844 ALIMERA SCIENCES INC 6120 WINDWARD PKWY STE 290 ALPHARETTA GA 30005 12/31/2018 02/15/2011 600-1603 ALK-ABELLO INC 2 CHANNEL DR PORT WASHINGTON NY 11050 12/31/2018 04/27/2009 South Dakota Board of Pharmacy Wholesale Distributors; Active, in good standing as of October 5, 2018 This document may be used as a Primary Source Verification Full License Firm Name DBA Address 1 Address 2 City State ZIP Code Expiration Issued 600-1565 ALKERMES INC 265 OLINGER CIRCLE WILMINGTON OH 45177 12/31/2018 02/02/2009 600-2142 ALLEGIS PHARMACEUTICALS LLC 276 NISSAN PKWY F100 CANTON MS 39046 12/31/2018 02/21/2013 600-2911 ALLERGAN USA, INC 5 GIRALDA FARMS MADISON NJ 07940 12/31/2018 07/03/2018 600-1865 ALMATICA PHARMA INC 10 BLOOMFIELD AVE PINE BROOK NJ 07058 12/31/2018 04/05/2011 600-2873 ALNYLAM PHARMACEUTICALS INC 300 THIRD ST CAMBRIDGE MA 02142 12/31/2018 02/23/2018 600-2489 ALVIX LABORATORIES LLC 6601 SUNPLEX DR OCEAN SPRINGS MS 39564 12/31/2018 11/03/2015 600-1706 ALVOGEN INC 10 BLOOMFIELD AVE BLDG B STE 2 PINE BROOK NJ 07058 12/31/2018 03/26/2010 600-1979 ALZA CORPORATION 700 EUBANKS DRIVE VACAVILLE CA 95688 12/31/2018 12/16/2011 600-1518 AMAG PHARMACEUTICALS INC 1100 WINTER ST WALTHAM MA 02451 12/31/2018 10/10/2008 600-2035 AMARIN PHARMA INC 1430 ROUTE 206 STE 200 BEDMINSTER NJ 07921 12/31/2018 05/09/2012 600-2943 AMATHEON ANIMAL HEALTH LLC dba AMATHEON 80 SW 8TH ST STE 2660 A MIAMI FL 33130 12/31/2018 08/24/2018 600-1862 AMATHEON INC 4300 SW 73RD AVE STE 110 MIAMI FL 33155 12/31/2018 04/04/2011 AMERICAN PHARMACEUTICAL dba AMERICAN PHARMACEUTICAL 600-2362 INGREDIENTS LLC DISTRIBUTORS 6650 HIGHLAND RD UNIT 302 WATERFORD MI 48327 12/31/2018 12/02/2014 600-0413 AMERICAN REGENT INC PO BOX 9001 ONE LUITPOLD DR SHIRLEY NY 11967 12/31/2018 10/17/1997 600-2288 AMERICAN WELDING & GAS INC 1909 W HWY 12 WILLMAR MN 56201 12/31/2018 04/14/2014 600-1416 AMERICARES FOUNDATION 88 HAMILTON AVE STAMFORD CT 06902 12/31/2018 01/31/2008 600-1595 AMERIGEN PHARMACEUTICALS INC 9 POLITO AVE STE 900 LYNDHURST NJ 07071 12/31/2018 04/16/2009 600-1151 AMERIPHARM INC dba MEDVANTX INC 2503 E 54TH ST N SIOUX FALLS SD 57104 12/31/2018 05/08/2006 600-0379 AMERISOURCE HEALTH SERVICES LLC dba AMERICAN HEALTH PACKAGING 2550 JOHN GLENN AVENUE SUITE A COLUMBUS OH 43217 12/31/2018 01/22/1997 AMERISOURCEBERGEN DRUG 600-2698 CORPORATION 12577 STATELINE RD OLIVE BRANCH MS 38645 12/31/2018 11/29/2016 AMERISOURCEBERGEN
Load more

Recommended publications
  • Report Title Election Report for Cases Closed Region(S) (Report Defaults
    Report Title Election Report for Cases Closed Region(s) Election Held Date Closed Date (Report Defaults) Between (Report Defaults) and (Report Defaults) Between 10/1/2016 and 9/30/2017 12:00:00 AM Case Type Case Name Labor Org 1 Name State City (Report Defaults) (All Choices) (All Choices) (Report Defaults) (Report Defaults) Election Report for Cases Closed NLRB Elections - Summary Time run: 10/16/2017 8:16:17 AM Case Type No. of Elections Percent Won by Union Total Employees Eligible to Vote Total Valid Votes for Total Valid Votes Against Total Elections 1391 65.0% 92,653 43,607 31,642 RC 1193 71.0% 79,750 37,631 26,806 RD 172 32.0% 12,319 5,757 4,573 RM 26 30.0% 584 219 263 NLRB Elections with 1 Labor Organization Time run: 10/16/2017 8:16:17 AM Region Case Number Case Name Case City State Election Number Valid Votes Labor Org 1 Name Stipulated Certification of Certification Case Closed Type Held Date of Votes for / Consent Representative of Results Closed Reason Eligible Against Labor / Directed Date (Win) Date (Loss) Date Voters Org 1 01, 34 01-RC-181492 GREEN LINE GROUP INC. RC DEDHAM 9/30/2016 211 57 93 INTERNATIONAL Directed WON 12/21/2016 Certific. of BROTHERHOOD OF Representative MA ELECTRICAL WORKERS LOCAL 1228, AFL-CIO 01, 34 01-RC-182252 RENZENBERGER, INC. RC WORCHESTER 9/12/2016 26 2 7 UNITED STEEL, PAPER AND Stipulated WON 10/6/2016 Certific. of FORESTRY, RUBBER, Representative MA MANUFACTURING, ENERGY, ALLIED INDUSTRIAL AND SERVICE WORKE 01, 34 01-RC-182433 J's Associates, LLC RC Springfield 9/8/2016 12 2 8 Area Trades Council of New Stipulated WON 10/3/2016 Certific.
    [Show full text]
  • S P O T L I G H T Pa R T I C I Pa N
    SPOTLIGHT PARTICIPANTS 12 Copyright © 2019 Mercer (US) Inc. All rights reserved. ORGANIZATION LISTING 3M (Minnesota Mining & Manufacturing) Atlas Energy Group LLC City of Overland Park, KS Cleveland Indians Baseball Co. A&E Television Networks Auburn University City of Winston-Salem, NC CliftonLarsonAllen, LLP A.O. Smith Corporation Automatic Data Processing California Health Care Foundation CMA CGM (America) LLC American Automobile Association, Inc., The Automobile Club of Southern California Cabot Oil & Gas Corporation CNH Industrial America LLC Accenture LLP AXA XL Cactus Feeders, Inc. CNO Financial Group Accudyne Industries, LLC Badger Meter, Inc. Cadmus Holding Company CNOOC Petroleum U.S.A. Inc. Advance Auto Parts Baltimore Orioles California Endowment, The CNX Resources ADVICS North America, Inc. Bank of the Ozarks, Inc. California ISO Colorado Rockies Baseball Club AECOM Building & Construction Bank of New York Mellon California Wellness Foundation Cobb Electric Membership Corporation AECOM Enterprise Baptist Health - FL Cambia Health Solutions (Regence Group) Coca-Cola Company, Inc., The AECOM Management Services Crestline Hotels & Resorts, LLC Canadian Imperial Bank of Commerce COG Operating, LLC Aera Energy Services Company Barnes & Noble, Inc. Canadian National Cognizant Technology Solutions Corporation Affinity Federal Credit Union BASF Corporation Canadian Pacific Railway CohnReznick LLP AgReserves Inc. Basin Electric Power Co-op Canadian Solar, Inc. Colby College Agri Beef Company Bates College Capital Group Companies, Inc., The Colonial Group, Inc. American International Group, Inc. (AIG) Battelle Memorial Institute Capital One Financial Corporation Columbia Sportswear Company Aimbridge Hospitality Baylor College of Medicine CarMax Auto Superstores, Inc. Columbia University American Institutes for Research BB&T Corporation Carilion Clinic Columbus McKinnon Corporation Air Liquide USA Blue Cross Blue Shield of Kansas Carrix, Inc.
    [Show full text]
  • Discovering and Developing Innovative New Medicines Designed to Extend and Enhance the Quality of Human Life
    ® Discovering and developing innovative new medicines designed to extend and enhance the quality of human life. 2011 Annual Report Company Profile Athersys is an international, clinical-stage biotechnology company that is focused on developing novel and proprietary best-in-class therapies designed to treat significant unmet medical needs that extend and enhance the quality of human life. The Company is developing MultiStem®, a patented, adult-derived “off-the- shelf” stem cell product platform for multiple disease indications in the inflammatory & immune, neurological and cardiovascular disease areas. Current clinical-stage programs include: an ongoing Phase II trial to treat inflammatory bowel disease (partnered with Pfizer); an ongoing Phase II trial to treat damage from ischemic stroke; a recently completed Phase I trial to treat damage from acute myocardial infarction (heart attack); and a recently completed Phase I trial to prevent or reduce GvHD. MultiStem® Production Process Athersys has forged a network of strategic Scalable & Consistent alliances and collaborations with leading pharmaceutical and biotechnology Isolate Material “Off-the-shelf” Product with from Qualified Commercial Scalability Thaw & Administer companies, as well as world- Adult Donor (No tissue matching– renowned research and clinical Lot Release & Product allogeneic product) Characterization Testing Hundreds of thousands institutions in the United to millions of doses States and Europe to PRODUCT STERILITY obtained per donor further develop its Cell Isolation
    [Show full text]
  • Corporate Ghg Inventorying and Target Setting Self-Assessment: V1.0
    APPENDIX Corporate GHG Inventorying and Target Setting Self - Assessment : V1.0 Development and Methodology April 2020 APPENDIX: CORPORATE GHG INVENTORYING AND TARGET SETTING SELF-ASSESSMENT: V1.0 Purpose of this Self-Assessment and How it Can Lead to Action Companies are often in a stronger position to improve their greenhouse gas (GHG) management efforts once they understand their relative performance compared to their peers. In response to stakeholder interest, this self-assessment is designed to help companies estimate, at a high level, how their GHG inventorying and target-setting approaches compare to large peer companies representing different industry sectors. Once companies estimate how their key GHG measurement and target-setting efforts compare to their peers, they can evaluate, in greater detail, how other companies approach GHG inventorying and target setting. Helping companies locate their GHG management efforts within the broader market may spur competition, garner internal support for widening the scope of their GHG inventories or setting more aggressive GHG reduction targets, and prioritize resources to implement GHG reduction activities. • Entry-level: For companies beginning to address their GHG emissions, this resource aims to help them identify which inventorying and target-setting actions reflect common business practices today and provide them with a roadmap for developing their own inventories and setting targets. • Intermediate: For companies further along their sustainability journey, this self- assessment can validate more advanced inventorying and target-setting behaviors that position them to deepen GHG emission reductions. • Advanced: For leading companies, this resource can also validate their efforts and encourage them to explore implementing more cutting edge GHG management efforts, eventually pushing such innovations into the mainstream and sharing practices with others.
    [Show full text]
  • A Day in the Life of PHMC 2005 Annual Report What a Difference a Day Makes!
    Philadelphia Health Management Corporation A day in the life of PHMC 2005 annual report What a difference a day makes! As I head home from work each evening, I find comfort in knowing that staff from PHMC and its affiliates have reached out to thousands of people since the day began. We believe it’s important to reach people where they are, so every day, we’re in community centers, schools, churches, and people’s homes—wherever we need to be to serve the region’s most vulnerable. In 2005, we were fortunate to bring some unique programs into our network of services: · The PHMC Care Clinic, formerly known as the St. Joseph’s Care Clinic, brings vital medical care to people living with HIV and AIDS in North Philadelphia. · The Bridge began managing the new Parkside E-3 Power Center in West Philadelphia, part of a Philadelphia Youth Network initiative that focuses on empowerment, education, and employment for out-of-school youth and youth returning from the juvenile justice system. · The Joseph J. Peters Institute (JJPI) started an innovative screening and counseling program for Philadelphia grade school children who act in sexually inappropriate ways. · The National Nursing Centers Consortium (NNCC) started its popular STUDENTS RUN Philly Style Program, which mentors Philadelphia students through running programs. · The Health Promotion Council (HPC) expanded its nutrition education work. In addition to their work in the School District of Philadelphia, HPC started working with the North Penn., Wissahickon and Souderton school districts in Montgomery County to fight obesity through promoting healthy eating and healthy lifestyles.
    [Show full text]
  • 2010 Annual Report
    2010 AnnuAl RepoRt Air Products Celebrating the Innovation of the Past and Its Promise for the Future Financial Highlights 6% 8% Merchant Gases United States 21% • 21% • • Tonnage Gases • Europe Consolidated Consolidated 41% Electronics and Asia • 39% • Sales by Performance Materials Sales by Business Segment Destination • Canada/Latin America/ROW • Equipment and Energy 32% 32% Millions of dollars, except per share 2010 2009 Change For the Year Sales $9,026 $8,256 9% Operating income 1,389 846 64% Operating income (A) 1,485 1,185 25% Net income attributable to Air Products 1,029 631 63% Capital expenditures (A) 1,298 1,475 (12)% Return on capital employed(A) 12.4 % 10.6 % Return on average Air Products shareholders’ equity (B) 19.9 % 13.3 % Operating margin 15.4 % 10.3 % Operating margin(A) 16.5% 14.3% Per Share DollarS Diluted earnings 4.74 2.96 60% Diluted earnings(A) 5.02 4.06 24% Dividends 1.92 1.79 7% Book value 25.94 22.68 14% at Year enD Air Products shareholders’ equity $5,547 $4,792 Shares outstanding (in millions) 214 211 Shareholders 8,300 8,600 Employees (C) 18,300 18,900 (A) Amounts are non-GAAP measures. See pages V and VI for reconciliation to GAAP results. (B) Calculated using income and five-quarter average Air Products shareholders’ equity from continuing operations. (C) Includes full- and part-time employees from continuing and discontinued operations. return on air Products Shareholders’ equity Sales earnings per Share Percentage using income and Air Products Billions of dollars Dollars—diluted basis shareholders’ equity from continuing operations 2010 19.9 2010 9.0 2010 4.74 2009 13.3 2009 8.3 2009 2.96 2008 20.1 2008 10.4 2008 4.15 2007 19.5 2007 9.1 2007 4.64 2006 15.1 2006 7.9 2006 3.18 Air Products | 2010 Annual Report Our Businesses Merchant Gases Industrial and medical customers throughout the world depend on our oxygen, nitrogen, argon, helium, hydrogen, and medical and specialty gases for a wide array of applications.
    [Show full text]
  • Sheffield Teaching Hospitals NHS Foundation Trust Procurement
    Sheffield Teaching Hospitals NHS Foundation Trust 07-JAN-2019 14:46:09 Procurement Transparency Payments December-2018 Supplier Value Paid 365 HEALTHCARE 2,730.00 3B TRAINING LTD 4,332.00 3M UNITED KINGDOM PLC 48.78 3M UNITEK UK (ORTHODONTIC PRODUCTS) 1,913.84 7 HILLS LEISURE TRUST 9,332.37 A & S DENTAL 196.56 A ALGEO LTD 31.36 A BOWNES WEBSTER 169.76 A CRAVEN 19.84 A CUMBERLIDGE LTD 4,780.56 A DAY 234.00 A FORRESTER 2,532.30 A GANNAWAY 30.56 A GRAFTON 1,398.90 A HOGG 100.00 A HOOGKAMER 65.77 A HOWARD 129.20 A J HURDLEY 39.10 A L CLINICIAN LIMITED 4,282.00 A LITTLEWOOD 32.00 A LITTLEWOOD 14.40 A M TIME SERVICES 112.68 A MARSHALL 568.40 A MAZAI 5,701.00 A P MACKIE 310.40 A R M ANDRZEJOWSKI 364.00 A RIDSDALE 7,873.86 A SLATER 260.91 A SOMERVILLE LTD 88.37 A SWAIN 15.60 A TAYLOR 29.00 A W BENT LTD 327.26 A WOOD 355.83 A WRIGHT 1,310.08 A&F SPRINKLERS LTD 302.40 A. GAGE OPTICIANS LTD 39.10 AAH PHARMACEUTICALS LTD 1,113,707.10 ABATRON LTD 346.18 ABBOTT LABORATORIES LTD 4,229.46 ABBOTT MEDICAL UK LTD 141,181.20 ABBOTT VASCULAR 48,466.80 ABBVIE LTD 17,765.18 ABILITY HANDLING LTD 482.98 AC MAINTENANCE LTD 5,206.80 ACCIDENT & EMERGENCY AGENCY LIMITED 792.56 Page 1 of 36 Supplier Value Paid ACCORD FLOORING LTD 5,780.92 ACE JANITORIAL SUPPLIES LIMITED 5,159.34 ACORN INDUSTRIAL SERVICES LTD 331.55 ACROSTAK 2,061.60 ACTION ON HEARING LOSS 99.67 ACTIVE DOCUMENTS LTD 2,094.00 ACUMED LTD 3,833.88 ADAM ROUILLY LTD 985.20 ADARE SEC LIMITED 197.90 ADEC DENTAL UK LTD 1,375.56 ADECCO UK LTD 32,195.88 ADEPT LOCUMS LTD 398.35 ADMIRAL DENTAL LABORATORY LTD 181.00
    [Show full text]
  • Creating Stakeholder Value Creating Stakeholder Value
    8446 Annual Report 2011_Annual Report 2011 15/03/2012 16:27 Page FC1 Shire plc Annual ReportShire 2011 Shire plc Annual Report 2011 Creating stakeholder value Creating stakeholder value Effective treatments and services Commitment to superior treatments Improved public for their patients health and societal value Better lives for patients Superior clinical Brave culture driving evidence and clear innovation to deliver economic benefits value to all Return to enable further investment shire.com 8446 Annual Report 2011_Annual Report 2011 15/03/2012 16:27 Page IFC1 Shire plc Annual Repo Shire trademarks The following are trademarks either owned or licensed by Shire plc or companies within the Shire Group (the “Group” or the “Company”) which are the subject of trademark registrations in certain territories, or which are owned by third parties as indicated and referred to in this Annual Report: ADDERALL XR® (mixed salts of a single entity amphetamine) AGRYLIN® (anagrelide hydrochloride) APLIGRAF® (trademark of Organogenesis, Inc. (“Organogenesis”)) APRISO® (trademark of Salix Pharmaceuticals, Ltd. (“Salix”)) ASACOL® (trademark of Medeva Pharma Suisse AG (used under license by Warner Chilcott Company, LLC (“Warner Chilcott”))) ATRIPLA® (trademark of Bristol Myers Squibb Company (“BMS”) and Gilead Sciences, Inc. (“Gilead”)) BERINERT P® (trademark of Aventis Behring GmbH) ® CALCICHEW range (calcium carbonate with or without vitamin D3) CARBATROL® (carbamazepine extended release capsules) CEREZYME® (trademark of Genzyme Corporation (“Genzyme”))
    [Show full text]
  • Post Conference Report
    Europe's leading industry update for all clinical development outsourcing professionals 10th Annual Congress and Exhibition 20 11 Leadership for successful clinical partnerships 15-18 November 2011, Cité Centre de Congrès, Lyon, France POST CONFERENCE REPORT • Record attendance for 2011, over 900+ clinical professionals registered to attend • Most comprehensive agenda , over 95+ hours researched interviews conducted • 150 speakers and 70+ practical case studies presented the latest clinical development in the industry • Largest ever group of Vice Presidents, Directors and Heads of Clinical with multi-million Euro purchasing power • Over 350 different companies attended across 31 countries • Partnerships in Clinical Trials Congress and Exhibition continues to be the market leading event for decision makers to attend • 87% of delegates were from Europe • Overall conference experience has been rated 4 out 5 amongst our attendees Participation Statistics Country Representation 20 11 Function Representation 20 11 Western Europe 48% General Managers 25% Vice President 5% Northern Europe 32% Business Development 19% CEO 4% USA 8% Clinical Operations 17% Account Directors 3% Eastern Europe 6% Outsourcing 12% Data Management 2% Southern Europe 4% Logistics Managers 11% Medical Directors 2% Rest of the World 2% Other 6% Alliance 1% Contract Research 5% www.ct-partnerships.com To register: Call: +44 (0) 20 7017 7481 Fax: +44 (0) 20 7017 7823 Email: [email protected] Reasons why PCT remains THE leading clinical conference to attend in
    [Show full text]
  • A Special Thank You to Our Bionj BIO 2015 Host Committee Members!
    A Special Thank You to Our BioNJ BIO 2015 Host Committee Members! Nicole Adams, Chromocell Corporation Geert Cauwenbergh, PhD, Dr. Med. Sc., RXi Pharma Sam Alexander, Pavese-McCormick Agency, Inc. Jean Chang, New Jersey Business Action Center Emil Andrusko, Benchworks Paul Chew, MD, Sanofi Domenick Argento, Merck Sharp & Dohme Corp. John Clarke, Cardinal Partners Chris Asakiewicz, PhD, Stevens Institute of Technology Steven Cohen, Morgan, Lewis & Bockius LLP Didi Asistin, Ontario Ministry of Economic Development, Mary Coleman, Agile Therapeutics Trade and Employment Linda Coles Kauffman, New Jersey Business Action Center Solomon Babani, Covance Karen Coviello, WithumSmith+Brown, PC Kim Baez, Helsinn Therapeutics (US), Inc. Kathleen Coviello, New Jersey Economic Development Richard Bagger, Celgene Corporation Authority Jane Baj, PTC Therapeutics, Inc. Irene Crespo, New Jersey Business Action Center Clara Barreneche, Catalonia Trade & Investment ACC10 NY Tony delCampo, Hackensack University Medical Center Gil Bashe, Makovsky + Company, Inc. Pamela Demain, MBA, CLP, Merck & Co., Inc. Brian Batchelder, Imclone Systems/Eli Lilly and Company Bill DeStefano, USI Insurance Services, LLC Patti Becton, Accenture Charles-Henry Dion, UBIFRANCE North America – Boston Office Thad Bench, Benchworks Debra Duffy, PhR, Elusys Therapeutics, Inc. Gina Bencivengo, NJEDA Regina Dutkowski, d3 Medicine Donna Bernard, BDO USA, LLP Jeff Elton, Accenture Kenneth Blank, PhD, Rowan University Bob Esposito, CPA, M.Ace, EisnerAmper, LLP Keith Bostian, PhD, Kean University Eddie Evans, NPS Pharmaceuticals Taryn Bostjanic, CPA, WithumSmith+Brown, PC Karla Ewalt, Princeton University Cheryl Braunstein, Helsinn Therapeutics (US), Inc. Bonnie Featherstone, BonaFide Staffing, LLC Michele Brown, Choose New Jersey Fred Feiner, Yankee Public Relations Linda Burns, Helsinn Therapeutics (US), Inc. Allison Finnegan, American Express Meetings & Events Michele Cahoone , VWR International, LLC Kit Ford, Taiho Oncology, Inc.
    [Show full text]
  • SHIRE PLC (Exact Name of Registrant As Specified in Its Charter)
    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2009 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 0-29630 SHIRE PLC (Exact name of registrant as specified in its charter) Jersey (Channel Islands) 98-0601486 (State or other jurisdiction of incorporation or (I.R.S. Employer Identification No.) organization) 5 Riverwalk, Citywest Business Campus, Dublin +353 1 429 7700 24, Republic of Ireland (Address of principal executive offices and zip code) (Registrant’s telephone number, including area code) Securities registered pursuant to Section 12(b) of the Act: Title of each class Name of exchange on which registered American Depositary Shares, each representing three NASDAQ Global Select Market Ordinary Shares 5 pence par value per share Securities registered pursuant to Section 12(g) of the Act: None (Title of class) 1 Indicate by check mark whether the Registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act Yes [X] No [ ] Indicate by check mark if the Registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act Yes [ ] No [X] Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
    [Show full text]
  • 2020 ANNUAL REPORT Statement of Intentions the Leadingage 1
    W�'�� changing our stripes 2020 ANNUAL REPORT Statement of Intentions The LeadingAge 1. To carry out our mission in ways that are always Quality First Elements ethical and in the expressed spirit of our stated of Quality mission. Dunwoody Village participates in the 2. To create an atmosphere of caring that treats all LeadingAge Quality First program, which residents in a dignified manner respecting helps organizations to achieve excellence individuality, privacy and personal choices. in aging services and earn public trust. By endorsing the Quality First principles, 3. To create health and wellness programs that serve Dunwoody pledges to work in partnership residents along the full continuum of care. with consumers and the government to 4. To support a quality management program that create an environment of high-quality care identifies, develops and implements and service. The ten elements of quality are: ongoing performance improvement projects. • Commitment 5. To cultivate teamwork in providing distinctive • Governance and Accountability high quality services. • Leading-Edge Care and Services 6. To provide a homelike and welcoming environ- • Community Involvement ment that is safe and secure. • Continuous Quality Improvement 7. To support our mission in a cost-efficient and • Human Resources Development effective manner. • Consumer-Friendly Information 8. To provide charitable Personal Care services to a • Consumer Participation limited number of qualified individuals, in keeping • Research Findings and Education with the vision of our founder, William Hood • Public Trust and Consumer Confidence Dunwoody. 9. To promote and develop strong community affilia- tions through residents, employees, and Trustees. 10. To create an atmosphere of growth and opportunity in order to attract and maintain employees who are committed to our Core Values of Teamwork, Respect, Integrity, Compassion, and Quality.
    [Show full text]